POP MART
09992
XIAOMI-W
01810
MEITUAN-W
03690
4
BABA-W
09988
5
HORIZONROBOT-W
09660
HK Stock MarketDetailed Quotes
01789 AK MEDICAL
- 5.690
- -0.080-1.39%
Market Closed Apr 29 16:08 CST
6.39BMarket Cap21.63P/E (TTM)
5.840High5.630Low3.33MVolume5.720Open5.770Pre Close18.93MTurnover0.30%Turnover Ratio21.63P/E (Static)1.12BShares6.43052wk High2.24P/B6.39BFloat Cap3.49052wk Low0.05Dividend TTM1.12BShs Float27.480Historical High0.045Dividend LFY3.64%Amplitude1.435Historical Low5.684Avg Price2000Lot Size0.79%Div YieldTTM0.79%Div Yield LFY
AK MEDICAL Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 23.08%1.35B | 1.30%657.1M | 3.97%1.09B | 22.11%648.69M | 38.17%1.05B | 18.67%531.21M | -26.46%761.44M | -6.54%447.63M | 11.73%1.04B | 9.41%478.98M |
| Operating income | 23.08%1.35B | 1.30%657.1M | 3.97%1.09B | 22.11%648.69M | 38.17%1.05B | 18.67%531.21M | -26.46%761.44M | -6.54%447.63M | 11.73%1.04B | 9.41%478.98M |
| Cost of sales | -28.33%-538.18M | -4.65%-258.62M | -0.91%-419.38M | -28.26%-247.12M | -58.48%-415.61M | -38.32%-192.68M | 18.26%-262.25M | 2.35%-139.3M | -13.19%-320.85M | -7.10%-142.66M |
| Operating expenses | -28.33%-538.18M | -4.65%-258.62M | -0.91%-419.38M | -28.26%-247.12M | -58.48%-415.61M | -38.32%-192.68M | 18.26%-262.25M | 2.35%-139.3M | -13.19%-320.85M | -7.10%-142.66M |
| Gross profit | 19.82%808.19M | -0.77%398.48M | 5.98%674.49M | 18.62%401.57M | 27.49%636.44M | 9.80%338.54M | -30.14%499.19M | -8.32%308.33M | 11.08%714.53M | 10.42%336.32M |
| Selling expenses | -10.10%-240.91M | 3.75%-113.01M | -21.49%-218.81M | -17.74%-117.41M | 3.86%-180.11M | -26.67%-99.71M | -21.57%-187.35M | -25.45%-78.72M | 12.11%-154.1M | 25.66%-62.75M |
| Administrative expenses | -7.87%-143.95M | 3.81%-72.31M | -12.79%-133.44M | -37.84%-75.17M | -12.34%-118.31M | -6.86%-54.54M | -26.86%-105.32M | -33.39%-51.04M | 9.96%-83.02M | 19.55%-38.26M |
| Research and development expenses | -1.52%-139.21M | 4.15%-63.58M | -23.69%-137.13M | -21.92%-66.33M | 1.95%-110.87M | -5.15%-54.4M | -7.71%-113.07M | -17.85%-51.74M | -30.36%-104.97M | -24.95%-43.9M |
| Impairment and provision | ---- | ---- | ---- | ---- | ---18.36M | ---- | ---- | ---- | ---8.85M | ---- |
| -Goodwill impairment | ---- | ---- | ---- | ---- | ---18.36M | ---- | ---- | ---- | ---8.85M | ---- |
| Special items of operating profit | -36.84%16.65M | 177.10%2.9M | 135.59%26.37M | -78.85%1.05M | 87.21%11.19M | 138.27%4.96M | 12.11%5.98M | 120.57%2.08M | -73.77%5.33M | -93.93%943K |
| Operating profit | 42.22%300.78M | 6.11%152.49M | -3.86%211.48M | 6.58%143.71M | 121.23%219.98M | 4.60%134.84M | -73.05%99.44M | -32.98%128.92M | 16.93%368.93M | 25.71%192.36M |
| Financing income | -3.02%19.04M | -29.75%10.03M | -3.31%19.63M | -2.28%14.28M | 122.59%20.31M | 442.55%14.61M | 18.77%9.12M | -40.35%2.69M | 30.61%7.68M | 31.44%4.52M |
| Earning before tax | 38.38%319.82M | 2.87%162.52M | -3.82%231.12M | 5.71%157.99M | 121.35%240.29M | 13.56%149.45M | -71.17%108.56M | -33.15%131.61M | 17.18%376.61M | 25.84%196.87M |
| Tax | 6.36%-45.9M | 8.43%-23.27M | -37.99%-49.01M | -8.51%-25.41M | -122.82%-35.52M | -16.35%-23.42M | 74.54%-15.94M | 40.80%-20.13M | -15.05%-62.6M | -26.42%-34M |
| After-tax profit from continuing operations | 50.42%273.93M | 5.04%139.25M | -11.07%182.1M | 5.19%132.57M | 121.09%204.77M | 13.05%126.03M | -70.50%92.62M | -31.55%111.48M | 17.61%314.01M | 25.72%162.87M |
| Earning after tax | 50.42%273.93M | 5.04%139.25M | -11.07%182.1M | 5.19%132.57M | 121.09%204.77M | 13.05%126.03M | -70.50%92.62M | -31.55%111.48M | 17.61%314.01M | 25.72%162.87M |
| Profit attributable to shareholders | 50.42%273.93M | 5.04%139.25M | -11.07%182.1M | 5.19%132.57M | 121.09%204.77M | 13.05%126.03M | -70.50%92.62M | -31.55%111.48M | 17.61%314.01M | 25.72%162.87M |
| Basic earnings per share | 56.25%0.25 | 0.00%0.12 | -11.11%0.16 | 9.09%0.12 | 125.00%0.18 | 10.00%0.11 | -71.43%0.08 | -33.33%0.1 | 7.69%0.28 | 25.00%0.15 |
| Diluted earnings per share | 50.00%0.24 | 0.00%0.12 | -11.11%0.16 | 9.09%0.12 | 125.00%0.18 | 10.00%0.11 | -71.43%0.08 | -33.33%0.1 | 12.00%0.28 | 25.00%0.15 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.